ERS Statement: Obstructive sleep-disordered breathing in children 2-18 years old. Risk factors, associated morbidity, predictors of persistent disease and assessment of disease severity

Athanasios G Kaditis (Athens, Greece)

Source: International Congress 2015 – Obstructive sleep apnoea in adults and children
Session: Obstructive sleep apnoea in adults and children
Session type: Session
Number: 442
Disease area: Sleep and breathing disorders

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Athanasios G Kaditis (Athens, Greece). ERS Statement: Obstructive sleep-disordered breathing in children 2-18 years old. Risk factors, associated morbidity, predictors of persistent disease and assessment of disease severity. International Congress 2015 – Obstructive sleep apnoea in adults and children

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Obstructive sleep-disordered breathing in children 2-18 years old: indications for treatment, stepwise treatment approach and recognition and management of persistent disease
Source: International Congress 2015 – Obstructive sleep apnoea in adults and children
Year: 2015



Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014

Does Nutritional Risk Screening 2002 correlate with  dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018

Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up.
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020


Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009

Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Obstructive sleep apnoea and risk of cardiovascular disease in men. A follow-up study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Modifiable risk factors for all-cause hospitalization in obstructive lung disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Patients with sleep apnoea(SA) and severe/difficult to treat asthma(SDTA) have worse asthma related clinical outcomes than those with no sleep apnoea
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016

Cycle length identifies complex sleep apnea in patients with chronic heart failure - A matched control study
Source: International Congress 2016 – Central sleep apnoea and the central regulation of obstructive and central sleep apneoa
Year: 2016

Ventilatory function as predictor of cardio-metabolic markers of cardiovascular disease: 10 year follow-up in young adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Prevalence of metabolic syndrome (MS) in a population of apneic patients:A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases
Year: 2016

Global and regional trends in mortality from chronic obstructive pulmonary disease: Their relation to poverty, smoking and population change
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014

Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005


Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Moderate obstructive sleep apnea and cardiovascular outcomes in elder patients: a propensity score matched, multicentric study (CPAGE-MODE study)
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study
Source: Eur Respir J, 49 (6) 1601361; 10.1183/13993003.01361-2016
Year: 2017